They may be currently doing similar clinical trialsReally ? .... not sure I agree with that statement given an announcement was made to the market about the basic 'safety' trial being undertaken in Perth; you really think they would sit on an actual trial being undertaken in a hospital setting and not announce it to the market ? There could also be compliance issues if they did ?
if it's all so bad why not just sell and move onYou are well aware, many invested in SPL for the DEP technology so why would we sell this close to the DEP phase 2 trials being completed even though is is looking like being extended yet again to FHCY2022; what you also fail to recognise is just because we invested for the DEP technology doesn't mean we don't have the right to express our disappointment in the incompetence of the Starpharma management associated with the poor performance of the range of SPL7013 products ?
You are obviously happy with the Vivagel, Condoms and Viraleze launches and subsequent minuscule revenue streams from same; well this week anyway ?
I do find it amusing that you were one of the main supporters for the
@antibotter push to get shareholders to unite and contact instos and get a possible EGM sorted, which went nowhere by the way apart from a basic letter, and yet you hammer anyone expressing their disappointment in the failure by management to launch a COVID-19 product during the midst of a once in a hundred year pandemic ?
I welcome you to do a search on our direct competitor SaNOtize and then the same on Viraleze - SaNOtize has left us in their dust so there is a reason why we are annoyed.... here's a basic example that I provided yesterday ....
https://hotcopper.com.au/threads/updated-viraleze™-information.6170333/page-46?post_id=56211818Enjoy your day
